The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats

We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In na...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 2021-12, Vol.26 (12), p.7257-7269
Hauptverfasser: de Carvalho, Cristiane Ribeiro, Lopes, Mark William, Constantino, Leandra C., Hoeller, Alexandre Ademar, de Melo, Hiago Murilo, Guarnieri, Ricardo, Linhares, Marcelo Neves, Bortolotto, Zuner Assis, Prediger, Rui Daniel, Latini, Alexandra, Lin, Katia, Licinio, Julio, Leal, Rodrigo Bainy, Walz, Roger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7269
container_issue 12
container_start_page 7257
container_title Molecular psychiatry
container_volume 26
creator de Carvalho, Cristiane Ribeiro
Lopes, Mark William
Constantino, Leandra C.
Hoeller, Alexandre Ademar
de Melo, Hiago Murilo
Guarnieri, Ricardo
Linhares, Marcelo Neves
Bortolotto, Zuner Assis
Prediger, Rui Daniel
Latini, Alexandra
Lin, Katia
Licinio, Julio
Leal, Rodrigo Bainy
Walz, Roger
description We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In naive Wistar rats, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala correlates negatively with innate anxiety-related behavior on the elevated plus maze ( n  = 20) but positively with expression of defensive-learned behavior (i.e., freezing) on Pavlovian aversive (fear) conditioning ( n  = 29). The microinfusion of ERK1/2 inhibitor (FR180204, n  = 8–13/group) or MEK inhibitor (U0126, n  = 8–9/group) into the basolateral amygdala did not affect anxiety-related behavior but impaired the evocation (anticipation) of conditioned-defensive behavior ( n  = 9–11/group). In conclusion, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala predicts anxiety in humans and the innate anxiety- and conditioned freezing behaviors in rats. However, the ERK1/2 in the basolateral AMY is only required for the expression of defensive-learned behavior. These results support a dissociate ERK-dependent mechanism in the amygdala between innate anxiety-like responses and the anticipation of learned-defensive behavior. These findings have implications for understanding highly prevalent psychiatric disorders related to the defensive circuit manifested by anxiety and fear. Highlights The P-ERK1,2/Total-ERK1,2 ratio in the amygdala (AMY) correlates negatively with anxiety symptoms in patients with mesial temporal lobe epilepsy. The P-ERK1,2/Total-ERK1,2 in the amygdala correlates negatively with the anxiety-like behavior and positively with freezing-learned behavior in naive rats. ERK1,2 in the basolateral amygdala is required for learned-defensive but not for the anxiety-like behavior expression in rats.
doi_str_mv 10.1038/s41380-021-01203-0
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2555965557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A694903367</galeid><sourcerecordid>A694903367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c552t-831a2af7ab94bffcb9ced88481260437f9efe3bb5455b0e5466408d8ee5136a93</originalsourceid><addsrcrecordid>eNp9kl9r1jAUxosobk6_gBcS8MabbkmTtOnlGK9_2ESQeR3S5vRtRpvUJH1ZP49f1LTvnCgiITkh53eecwJPlr0m-JxgKi4CI1TgHBckx6TANMdPslPCqjLnvBJP053yOmdEsJPsRQh3GK9J_jw7oYySEmN2mv247QHtvl6jqXchbb8MKhpn0QAHGAIyFsVEqHHZazUoNHnQpo1I2XsDcUFhGafoxg3s51HZkFIafd5dX6yqxvamMZugNiG41qgIK2xT3MgBlLegkYYObDAHQA306mCc3zS9iuFl9qxTQ4BXD_Es-_Z-d3v1Mb_58uHT1eVN3nJexFxQogrVVaqpWdN1bVO3oIVgghQlZrTq6tSCNg1nnDcYOCtLhoUWAJzQUtX0LHt31J28-z5DiHI0oYVhUBbcHGTBOa_LdFQJffsXeudmb9N0sihpwVLb1PKR2qsBpLGdi161q6i8LGtWY0rLVev8H1RaGkbTOgudSe9_FBTHgta7EDx0cvJmVH6RBMvVGfLoDJmcITdnSJyK3jxMPDcj6MeSX1ZIAD0CIaXsHvzvL_1H9ie-ecRb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2632488404</pqid></control><display><type>article</type><title>The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>de Carvalho, Cristiane Ribeiro ; Lopes, Mark William ; Constantino, Leandra C. ; Hoeller, Alexandre Ademar ; de Melo, Hiago Murilo ; Guarnieri, Ricardo ; Linhares, Marcelo Neves ; Bortolotto, Zuner Assis ; Prediger, Rui Daniel ; Latini, Alexandra ; Lin, Katia ; Licinio, Julio ; Leal, Rodrigo Bainy ; Walz, Roger</creator><creatorcontrib>de Carvalho, Cristiane Ribeiro ; Lopes, Mark William ; Constantino, Leandra C. ; Hoeller, Alexandre Ademar ; de Melo, Hiago Murilo ; Guarnieri, Ricardo ; Linhares, Marcelo Neves ; Bortolotto, Zuner Assis ; Prediger, Rui Daniel ; Latini, Alexandra ; Lin, Katia ; Licinio, Julio ; Leal, Rodrigo Bainy ; Walz, Roger</creatorcontrib><description>We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In naive Wistar rats, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala correlates negatively with innate anxiety-related behavior on the elevated plus maze ( n  = 20) but positively with expression of defensive-learned behavior (i.e., freezing) on Pavlovian aversive (fear) conditioning ( n  = 29). The microinfusion of ERK1/2 inhibitor (FR180204, n  = 8–13/group) or MEK inhibitor (U0126, n  = 8–9/group) into the basolateral amygdala did not affect anxiety-related behavior but impaired the evocation (anticipation) of conditioned-defensive behavior ( n  = 9–11/group). In conclusion, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala predicts anxiety in humans and the innate anxiety- and conditioned freezing behaviors in rats. However, the ERK1/2 in the basolateral AMY is only required for the expression of defensive-learned behavior. These results support a dissociate ERK-dependent mechanism in the amygdala between innate anxiety-like responses and the anticipation of learned-defensive behavior. These findings have implications for understanding highly prevalent psychiatric disorders related to the defensive circuit manifested by anxiety and fear. Highlights The P-ERK1,2/Total-ERK1,2 ratio in the amygdala (AMY) correlates negatively with anxiety symptoms in patients with mesial temporal lobe epilepsy. The P-ERK1,2/Total-ERK1,2 in the amygdala correlates negatively with the anxiety-like behavior and positively with freezing-learned behavior in naive rats. ERK1,2 in the basolateral amygdala is required for learned-defensive but not for the anxiety-like behavior expression in rats.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/s41380-021-01203-0</identifier><identifier>PMID: 34316004</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/337 ; 631/378 ; 631/45 ; 692/699/476 ; 82/80 ; Amygdala ; Amygdala (Brain) ; Amygdala - metabolism ; Animals ; Anxiety ; Anxiety - metabolism ; Behavior ; Behavioral Sciences ; Biological Psychology ; Complications and side effects ; Defensive behavior ; Defensiveness (Psychology) ; Development and progression ; Drug resistance ; Epilepsy ; Extracellular signal-regulated kinase ; Fear ; Health aspects ; Humans ; Learning ; Medicine ; Medicine &amp; Public Health ; MEK inhibitors ; Mental disorders ; Mitogen-Activated Protein Kinase 1 - antagonists &amp; inhibitors ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 - antagonists &amp; inhibitors ; Mitogen-Activated Protein Kinase 3 - metabolism ; Mitogen-Activated Protein Kinase Kinases - metabolism ; Neurosciences ; Pharmacotherapy ; Phosphorylation ; Physiological aspects ; Protein kinases ; Psychiatric research ; Psychiatry ; Rats ; Rats, Wistar ; Risk factors ; Rodents ; Temporal lobe ; Temporal lobe epilepsy ; Tonic immobility</subject><ispartof>Molecular psychiatry, 2021-12, Vol.26 (12), p.7257-7269</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature Limited.</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c552t-831a2af7ab94bffcb9ced88481260437f9efe3bb5455b0e5466408d8ee5136a93</citedby><cites>FETCH-LOGICAL-c552t-831a2af7ab94bffcb9ced88481260437f9efe3bb5455b0e5466408d8ee5136a93</cites><orcidid>0000-0001-7526-1502 ; 0000-0002-5401-7524 ; 0000-0002-5513-8061 ; 0000-0002-4435-6768 ; 0000-0003-0523-4351 ; 0000-0003-2536-6888 ; 0000-0002-5292-8455 ; 0000-0002-9875-6687 ; 0000-0002-8152-7773 ; 0000-0002-7547-6463 ; 0000-0001-6905-5884</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41380-021-01203-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41380-021-01203-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34316004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Carvalho, Cristiane Ribeiro</creatorcontrib><creatorcontrib>Lopes, Mark William</creatorcontrib><creatorcontrib>Constantino, Leandra C.</creatorcontrib><creatorcontrib>Hoeller, Alexandre Ademar</creatorcontrib><creatorcontrib>de Melo, Hiago Murilo</creatorcontrib><creatorcontrib>Guarnieri, Ricardo</creatorcontrib><creatorcontrib>Linhares, Marcelo Neves</creatorcontrib><creatorcontrib>Bortolotto, Zuner Assis</creatorcontrib><creatorcontrib>Prediger, Rui Daniel</creatorcontrib><creatorcontrib>Latini, Alexandra</creatorcontrib><creatorcontrib>Lin, Katia</creatorcontrib><creatorcontrib>Licinio, Julio</creatorcontrib><creatorcontrib>Leal, Rodrigo Bainy</creatorcontrib><creatorcontrib>Walz, Roger</creatorcontrib><title>The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In naive Wistar rats, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala correlates negatively with innate anxiety-related behavior on the elevated plus maze ( n  = 20) but positively with expression of defensive-learned behavior (i.e., freezing) on Pavlovian aversive (fear) conditioning ( n  = 29). The microinfusion of ERK1/2 inhibitor (FR180204, n  = 8–13/group) or MEK inhibitor (U0126, n  = 8–9/group) into the basolateral amygdala did not affect anxiety-related behavior but impaired the evocation (anticipation) of conditioned-defensive behavior ( n  = 9–11/group). In conclusion, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala predicts anxiety in humans and the innate anxiety- and conditioned freezing behaviors in rats. However, the ERK1/2 in the basolateral AMY is only required for the expression of defensive-learned behavior. These results support a dissociate ERK-dependent mechanism in the amygdala between innate anxiety-like responses and the anticipation of learned-defensive behavior. These findings have implications for understanding highly prevalent psychiatric disorders related to the defensive circuit manifested by anxiety and fear. Highlights The P-ERK1,2/Total-ERK1,2 ratio in the amygdala (AMY) correlates negatively with anxiety symptoms in patients with mesial temporal lobe epilepsy. The P-ERK1,2/Total-ERK1,2 in the amygdala correlates negatively with the anxiety-like behavior and positively with freezing-learned behavior in naive rats. ERK1,2 in the basolateral amygdala is required for learned-defensive but not for the anxiety-like behavior expression in rats.</description><subject>631/337</subject><subject>631/378</subject><subject>631/45</subject><subject>692/699/476</subject><subject>82/80</subject><subject>Amygdala</subject><subject>Amygdala (Brain)</subject><subject>Amygdala - metabolism</subject><subject>Animals</subject><subject>Anxiety</subject><subject>Anxiety - metabolism</subject><subject>Behavior</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Complications and side effects</subject><subject>Defensive behavior</subject><subject>Defensiveness (Psychology)</subject><subject>Development and progression</subject><subject>Drug resistance</subject><subject>Epilepsy</subject><subject>Extracellular signal-regulated kinase</subject><subject>Fear</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Learning</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>MEK inhibitors</subject><subject>Mental disorders</subject><subject>Mitogen-Activated Protein Kinase 1 - antagonists &amp; inhibitors</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3 - antagonists &amp; inhibitors</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Mitogen-Activated Protein Kinase Kinases - metabolism</subject><subject>Neurosciences</subject><subject>Pharmacotherapy</subject><subject>Phosphorylation</subject><subject>Physiological aspects</subject><subject>Protein kinases</subject><subject>Psychiatric research</subject><subject>Psychiatry</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>Temporal lobe</subject><subject>Temporal lobe epilepsy</subject><subject>Tonic immobility</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kl9r1jAUxosobk6_gBcS8MabbkmTtOnlGK9_2ESQeR3S5vRtRpvUJH1ZP49f1LTvnCgiITkh53eecwJPlr0m-JxgKi4CI1TgHBckx6TANMdPslPCqjLnvBJP053yOmdEsJPsRQh3GK9J_jw7oYySEmN2mv247QHtvl6jqXchbb8MKhpn0QAHGAIyFsVEqHHZazUoNHnQpo1I2XsDcUFhGafoxg3s51HZkFIafd5dX6yqxvamMZugNiG41qgIK2xT3MgBlLegkYYObDAHQA306mCc3zS9iuFl9qxTQ4BXD_Es-_Z-d3v1Mb_58uHT1eVN3nJexFxQogrVVaqpWdN1bVO3oIVgghQlZrTq6tSCNg1nnDcYOCtLhoUWAJzQUtX0LHt31J28-z5DiHI0oYVhUBbcHGTBOa_LdFQJffsXeudmb9N0sihpwVLb1PKR2qsBpLGdi161q6i8LGtWY0rLVev8H1RaGkbTOgudSe9_FBTHgta7EDx0cvJmVH6RBMvVGfLoDJmcITdnSJyK3jxMPDcj6MeSX1ZIAD0CIaXsHvzvL_1H9ie-ecRb</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>de Carvalho, Cristiane Ribeiro</creator><creator>Lopes, Mark William</creator><creator>Constantino, Leandra C.</creator><creator>Hoeller, Alexandre Ademar</creator><creator>de Melo, Hiago Murilo</creator><creator>Guarnieri, Ricardo</creator><creator>Linhares, Marcelo Neves</creator><creator>Bortolotto, Zuner Assis</creator><creator>Prediger, Rui Daniel</creator><creator>Latini, Alexandra</creator><creator>Lin, Katia</creator><creator>Licinio, Julio</creator><creator>Leal, Rodrigo Bainy</creator><creator>Walz, Roger</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7526-1502</orcidid><orcidid>https://orcid.org/0000-0002-5401-7524</orcidid><orcidid>https://orcid.org/0000-0002-5513-8061</orcidid><orcidid>https://orcid.org/0000-0002-4435-6768</orcidid><orcidid>https://orcid.org/0000-0003-0523-4351</orcidid><orcidid>https://orcid.org/0000-0003-2536-6888</orcidid><orcidid>https://orcid.org/0000-0002-5292-8455</orcidid><orcidid>https://orcid.org/0000-0002-9875-6687</orcidid><orcidid>https://orcid.org/0000-0002-8152-7773</orcidid><orcidid>https://orcid.org/0000-0002-7547-6463</orcidid><orcidid>https://orcid.org/0000-0001-6905-5884</orcidid></search><sort><creationdate>20211201</creationdate><title>The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats</title><author>de Carvalho, Cristiane Ribeiro ; Lopes, Mark William ; Constantino, Leandra C. ; Hoeller, Alexandre Ademar ; de Melo, Hiago Murilo ; Guarnieri, Ricardo ; Linhares, Marcelo Neves ; Bortolotto, Zuner Assis ; Prediger, Rui Daniel ; Latini, Alexandra ; Lin, Katia ; Licinio, Julio ; Leal, Rodrigo Bainy ; Walz, Roger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c552t-831a2af7ab94bffcb9ced88481260437f9efe3bb5455b0e5466408d8ee5136a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>631/337</topic><topic>631/378</topic><topic>631/45</topic><topic>692/699/476</topic><topic>82/80</topic><topic>Amygdala</topic><topic>Amygdala (Brain)</topic><topic>Amygdala - metabolism</topic><topic>Animals</topic><topic>Anxiety</topic><topic>Anxiety - metabolism</topic><topic>Behavior</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Complications and side effects</topic><topic>Defensive behavior</topic><topic>Defensiveness (Psychology)</topic><topic>Development and progression</topic><topic>Drug resistance</topic><topic>Epilepsy</topic><topic>Extracellular signal-regulated kinase</topic><topic>Fear</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Learning</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>MEK inhibitors</topic><topic>Mental disorders</topic><topic>Mitogen-Activated Protein Kinase 1 - antagonists &amp; inhibitors</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3 - antagonists &amp; inhibitors</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Mitogen-Activated Protein Kinase Kinases - metabolism</topic><topic>Neurosciences</topic><topic>Pharmacotherapy</topic><topic>Phosphorylation</topic><topic>Physiological aspects</topic><topic>Protein kinases</topic><topic>Psychiatric research</topic><topic>Psychiatry</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>Temporal lobe</topic><topic>Temporal lobe epilepsy</topic><topic>Tonic immobility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Carvalho, Cristiane Ribeiro</creatorcontrib><creatorcontrib>Lopes, Mark William</creatorcontrib><creatorcontrib>Constantino, Leandra C.</creatorcontrib><creatorcontrib>Hoeller, Alexandre Ademar</creatorcontrib><creatorcontrib>de Melo, Hiago Murilo</creatorcontrib><creatorcontrib>Guarnieri, Ricardo</creatorcontrib><creatorcontrib>Linhares, Marcelo Neves</creatorcontrib><creatorcontrib>Bortolotto, Zuner Assis</creatorcontrib><creatorcontrib>Prediger, Rui Daniel</creatorcontrib><creatorcontrib>Latini, Alexandra</creatorcontrib><creatorcontrib>Lin, Katia</creatorcontrib><creatorcontrib>Licinio, Julio</creatorcontrib><creatorcontrib>Leal, Rodrigo Bainy</creatorcontrib><creatorcontrib>Walz, Roger</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Carvalho, Cristiane Ribeiro</au><au>Lopes, Mark William</au><au>Constantino, Leandra C.</au><au>Hoeller, Alexandre Ademar</au><au>de Melo, Hiago Murilo</au><au>Guarnieri, Ricardo</au><au>Linhares, Marcelo Neves</au><au>Bortolotto, Zuner Assis</au><au>Prediger, Rui Daniel</au><au>Latini, Alexandra</au><au>Lin, Katia</au><au>Licinio, Julio</au><au>Leal, Rodrigo Bainy</au><au>Walz, Roger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>26</volume><issue>12</issue><spage>7257</spage><epage>7269</epage><pages>7257-7269</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In naive Wistar rats, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala correlates negatively with innate anxiety-related behavior on the elevated plus maze ( n  = 20) but positively with expression of defensive-learned behavior (i.e., freezing) on Pavlovian aversive (fear) conditioning ( n  = 29). The microinfusion of ERK1/2 inhibitor (FR180204, n  = 8–13/group) or MEK inhibitor (U0126, n  = 8–9/group) into the basolateral amygdala did not affect anxiety-related behavior but impaired the evocation (anticipation) of conditioned-defensive behavior ( n  = 9–11/group). In conclusion, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala predicts anxiety in humans and the innate anxiety- and conditioned freezing behaviors in rats. However, the ERK1/2 in the basolateral AMY is only required for the expression of defensive-learned behavior. These results support a dissociate ERK-dependent mechanism in the amygdala between innate anxiety-like responses and the anticipation of learned-defensive behavior. These findings have implications for understanding highly prevalent psychiatric disorders related to the defensive circuit manifested by anxiety and fear. Highlights The P-ERK1,2/Total-ERK1,2 ratio in the amygdala (AMY) correlates negatively with anxiety symptoms in patients with mesial temporal lobe epilepsy. The P-ERK1,2/Total-ERK1,2 in the amygdala correlates negatively with the anxiety-like behavior and positively with freezing-learned behavior in naive rats. ERK1,2 in the basolateral amygdala is required for learned-defensive but not for the anxiety-like behavior expression in rats.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34316004</pmid><doi>10.1038/s41380-021-01203-0</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-7526-1502</orcidid><orcidid>https://orcid.org/0000-0002-5401-7524</orcidid><orcidid>https://orcid.org/0000-0002-5513-8061</orcidid><orcidid>https://orcid.org/0000-0002-4435-6768</orcidid><orcidid>https://orcid.org/0000-0003-0523-4351</orcidid><orcidid>https://orcid.org/0000-0003-2536-6888</orcidid><orcidid>https://orcid.org/0000-0002-5292-8455</orcidid><orcidid>https://orcid.org/0000-0002-9875-6687</orcidid><orcidid>https://orcid.org/0000-0002-8152-7773</orcidid><orcidid>https://orcid.org/0000-0002-7547-6463</orcidid><orcidid>https://orcid.org/0000-0001-6905-5884</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-4184
ispartof Molecular psychiatry, 2021-12, Vol.26 (12), p.7257-7269
issn 1359-4184
1476-5578
language eng
recordid cdi_proquest_miscellaneous_2555965557
source MEDLINE; Springer Nature - Complete Springer Journals
subjects 631/337
631/378
631/45
692/699/476
82/80
Amygdala
Amygdala (Brain)
Amygdala - metabolism
Animals
Anxiety
Anxiety - metabolism
Behavior
Behavioral Sciences
Biological Psychology
Complications and side effects
Defensive behavior
Defensiveness (Psychology)
Development and progression
Drug resistance
Epilepsy
Extracellular signal-regulated kinase
Fear
Health aspects
Humans
Learning
Medicine
Medicine & Public Health
MEK inhibitors
Mental disorders
Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors
Mitogen-Activated Protein Kinase 3 - metabolism
Mitogen-Activated Protein Kinase Kinases - metabolism
Neurosciences
Pharmacotherapy
Phosphorylation
Physiological aspects
Protein kinases
Psychiatric research
Psychiatry
Rats
Rats, Wistar
Risk factors
Rodents
Temporal lobe
Temporal lobe epilepsy
Tonic immobility
title The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A11%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20ERK%20phosphorylation%20levels%20in%20the%20amygdala%20predict%20anxiety%20symptoms%20in%20humans%20and%20MEK/ERK%20inhibition%20dissociates%20innate%20and%20learned%20defensive%20behaviors%20in%20rats&rft.jtitle=Molecular%20psychiatry&rft.au=de%20Carvalho,%20Cristiane%20Ribeiro&rft.date=2021-12-01&rft.volume=26&rft.issue=12&rft.spage=7257&rft.epage=7269&rft.pages=7257-7269&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/s41380-021-01203-0&rft_dat=%3Cgale_proqu%3EA694903367%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2632488404&rft_id=info:pmid/34316004&rft_galeid=A694903367&rfr_iscdi=true